Xuchang KETOP Testing Research Institute Co.,Ltd (003008.SZ)
CNY 19.34
(0.78%)
CNY 19.34
(0.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 107.16 Million | 107.8 Million | 88.69 Million | 102.18 Million | 126.92 Million | 119.83 Million |
| Net Income | 58.79 Million | 69 Million | 64.25 Million | 74.25 Million | 108.21 Million | 104.84 Million |
| Depreciation & Amortization | 55.92 Million | 38.21 Million | 32.15 Million | 31.26 Million | 29.25 Million | 14.66 Million |
| Deferred income taxes | 90.16 Thousand | 335.93 Thousand | 700.24 Thousand | -656.44 Thousand | -11.41 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.05 Million | 13.07 Million | 2.75 Million | -1.95 Million | -8.86 Million | 1.47 Million |
| Other non-cash items | -11.6 Million | -12.48 Million | -10.46 Million | -1.38 Million | -1.68 Million | -1.14 Million |
| Investing Cash Flow | -168.45 Million | -29.78 Million | -140.87 Million | -488.95 Million | -114.78 Million | -59.61 Million |
| Investments in PPE | -47.74 Million | -97.68 Million | -86.47 Million | -49.86 Million | -116.46 Million | -101.92 Million |
| Acquisitions | 0.91 | 22.67 Thousand | 172.74 Thousand | 49.86 Million | 116.46 Million | - |
| Investment purchases | -1.07 Billion | -1.07 Billion | -1.13 Billion | -692.5 Million | -472 Million | -365.5 Million |
| Sales/Maturities of investments | 954.26 Million | 1.13 Billion | 1.08 Billion | 253.4 Million | 473.67 Million | 407.48 Million |
| Other Investing Activities | 21.68 Thousand | 0.44 | 0.58 | -49.86 Million | -116.46 Million | 330.31 Thousand |
| Financing Cash Flow | -40.18 Million | -40.18 Million | -48.09 Million | 561.31 Million | -30 Million | -24 Million |
| Debt repayment | -189.55 Thousand | -183.6 Thousand | -99 Thousand | - | - | - |
| Dividends payments | -40 Million | -40 Million | -48 Million | - | -30 Million | -24 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -189.55 Thousand | -183.6 Thousand | -99 Thousand | 561.31 Million | - | - |
| Accounts receivables | -13.3 Million | 896.14 Thousand | 7.32 Million | -9.44 Million | -4.71 Million | -14.1 Million |
| Accounts payables | 17.57 Million | 12.82 Million | -4.49 Million | 8.33 Million | -3.79 Million | - |
| Inventory | -305.38 Thousand | -982.26 Thousand | -773.94 Thousand | -191.65 Thousand | -349.32 Thousand | -566.49 Thousand |
| Other working capital | 4.35 Million | 335.93 Thousand | 700.24 Thousand | -656.44 Thousand | -11.41 Thousand | 2.03 Million |
| Cash at beginning of period | 183.69 Million | 145.85 Million | 246.12 Million | 71.57 Million | 89.44 Million | 53.21 Million |
| Cash at end of period | 82.2 Million | 183.69 Million | 145.85 Million | 246.12 Million | 71.57 Million | 89.44 Million |
| Capital Expenditure | -47.74 Million | -97.68 Million | -86.47 Million | -49.86 Million | -116.46 Million | -101.92 Million |
| Effect of forex changes on cash | 0.47 | - | - | 0.12 | 0.30 | - |
| Net cash flow / Change in cash | -101.48 Million | 37.84 Million | -100.27 Million | 174.54 Million | -17.86 Million | 36.22 Million |
| Free Cash Flow | 59.42 Million | 10.12 Million | 2.21 Million | 52.32 Million | 10.46 Million | 17.91 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 26.21 Million | 13.11 Million | 58.79 Million | 22.24 Million | 15.15 Million |
| Depreciation & Amortization | - | 13.2 Million | 13.2 Million | 55.92 Million | 55.92 Million | -27.92 Million |
| Deferred income taxes | - | - | - | 90.16 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 8.08 Million | - | 4.05 Million | -13.61 Million | 3.59 Million |
| Other non-cash items | - | 16.3 Million | 10.11 Million | -11.6 Million | -22.24 Million | 40.11 Million |
| Investing Cash Flow | -12.13 Million | -376.12 Million | 348.59 Million | -168.45 Million | -158.04 Million | 90.49 Million |
| Investments in PPE | -12.13 Million | -6.15 Million | -15.43 Million | -47.74 Million | -10.18 Million | -16.08 Million |
| Acquisitions | - | 25.74 Thousand | - | 0.91 | - | 21.68 Thousand |
| Investment purchases | - | -510 Million | - | -1.07 Billion | -615 Million | -25 Million |
| Sales/Maturities of investments | - | 140 Million | 364.02 Million | 954.26 Million | 467.13 Million | 131.55 Million |
| Other Investing Activities | - | -367.39 Million | 0.54 | 21.68 Thousand | 0.84 | 0.81 |
| Financing Cash Flow | -36.44 Million | -24.04 Million | -48.45 Thousand | -40.18 Million | -48.45 Thousand | -48.45 Thousand |
| Debt repayment | - | - | - | -189.55 Thousand | - | - |
| Dividends payments | -36.4 Million | -24 Million | - | -40 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -48.45 Thousand | 48.45 Thousand | -48.45 Thousand | -189.55 Thousand | -48.45 Thousand | -48.45 Thousand |
| Accounts receivables | - | 7.82 Million | - | -13.3 Million | -13.3 Million | 3.6 Million |
| Accounts payables | - | - | - | 17.57 Million | - | - |
| Inventory | - | 263.27 Thousand | - | -305.38 Thousand | -305.38 Thousand | -16.13 Thousand |
| Other working capital | - | - | - | 4.35 Million | - | - |
| Cash at beginning of period | 83.12 Million | 453.98 Million | 82.2 Million | 183.69 Million | 204.01 Million | 84.17 Million |
| Cash at end of period | 55.96 Million | 83.12 Million | 453.98 Million | 82.2 Million | 82.2 Million | 204.01 Million |
| Capital Expenditure | -12.13 Million | -6.15 Million | -15.43 Million | -47.74 Million | -10.18 Million | -16.08 Million |
| Effect of forex changes on cash | - | - | - | 0.47 | - | -1.55 Million |
| Net cash flow / Change in cash | -27.16 Million | -370.85 Million | 371.77 Million | -101.48 Million | -121.8 Million | 119.83 Million |
| Free Cash Flow | -12.13 Million | 23.16 Million | 7.79 Million | 59.42 Million | 26.1 Million | 14.85 Million |
ICR
JEV
ICNOF
3481
BSSR
HIO